Table: begin end state 1 22 cytoplasmic 23 51 transmembrane 52 62 non-cytoplasmic 63 85 transmembrane 86 96 cytoplasmic 97 115 transmembrane 116 120 non-cytoplasmic 121 142 transmembrane 143 163 cytoplasmic 164 184 transmembrane 185 195 non-cytoplasmic 196 215 transmembrane 216 244 cytoplasmic 245 264 transmembrane 265 283 non-cytoplasmic 284 303 transmembrane 304 313 cytoplasmic 314 333 transmembrane 334 338 non-cytoplasmic 339 362 transmembrane 363 372 cytoplasmic 373 395 transmembrane 396 406 non-cytoplasmic 407 425 transmembrane 426 436 cytoplasmic
Input: >RR42_RS21430 FitnessBrowser__Cup4G11:RR42_RS21430 MTDLSAPLLDAPPSAEEKRKRVYAIVAASSGNLVEWFDFYVYAFCAIYFAGSFFPKSDPT AQLLNTAGVFAAGFLMRPIGGWLFGRIADRHGRKNSLLISVTMMCCGSLLIASLPTYNSI GAWAPALLLVARLLQGLSVGGEYGTTATYMSEVALKGQRGFFSSFQYVTLIGGQLLAVLV VVVLQQFLDEAELKAWGWRIPFVIGAITAVVALFLRRTLHETTSAATRASKEAGTLTELF RNHKAAFFTVLGYTAGGSLIFYTFTTYMQKYLVNSAGMSIKTASYVMTGCLFFYMCMQPF FGALSDRIGRRTNMLLFGALGTLATVPILTALGSVKSPFVAFALISLALAIVSLYTSISG IVKAEMFPTEIRALGVGLAYAVANAIFGGSAEYVALDLKSLGHESSFYWYVTAMMVIVFL VSFRLPRQARYLHHEH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server